Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
mosquito-bourne illness
Manufacturing
Valneva nabs $33M US supply pact for Japanese encephalitis shot
Valneva won a $33 million contract to supply the U.S. with vaccines for Japanese encephalitis, which is endemic in Southeast Asia, India and China.
Joseph Keenan
Feb 3, 2025 11:32am
FDA signs off on Valneva's chikungunya vaccine Ixchiq
Nov 10, 2023 9:55am
Scientists weigh Zika challenge study: report
Sep 18, 2018 9:50am
An all-in-one mosquito-borne diseases vaccine? NIH is working on it
Feb 21, 2017 3:40pm
India/U.S. plan collaboration on dengue fever vaccine
Sep 2, 2016 6:34am
Themis pushes into PhII with Chikungunya vax candidate
Aug 31, 2016 8:42am
.jpg?VersionId=r72tTedUCU7e8jFmoH.kb_bE4jzZ91ct)
